Related Experiment Video
Updated: Jul 17, 2026
05:34
Simple and Effective Procedure for Hemostasis in Mouse Arteries
Published on: November 28, 2025
Clot stabilization for the prevention of bleeding.
Lisa Payne Rojkjaer1, Rasmus Rojkjaer
1Clinical Development, Novartis Pharmaceuticals, One Health Plaza, East Hanover, NJ 07936-1080, USA. lisa.rojkaer@novartis.com
Hematology/Oncology Clinics of North America
|January 30, 2007
Summary
New hemostasis strategies focus on clot stabilization and inhibiting fibrinolysis to control bleeding. This approach aims to reduce blood loss and the need for transfusions in patients with nonsurgical bleeding.
Area of Science:
- Biochemistry
- Hematology
- Physiology
Background:
- Coagulation is a complex process initiated by tissue factor (TF) and factor VII (FVII), leading to fibrin clot formation at sites of vascular injury.
- Thrombin is crucial not only for clot formation but also for stabilizing the clot by activating thrombin activatable fibrinolysis inhibitor (TAFI) and factor XIII (FXIII).
Purpose of the Study:
- To explore novel concepts in localized hemostasis.
- To investigate the role of clot stabilization and fibrinolysis inhibition in controlling bleeding.
Main Methods:
- Review of current understanding of coagulation and fibrinolysis pathways.
- Discussion of emerging strategies for hemostasis control.
Main Results:
- Existing antifibrinolytic agents are used in surgery to limit blood loss but are insufficient for many nonsurgical bleeding cases.
- New concepts highlight the potential of enhancing clot stability and inhibiting fibrinolysis for effective bleeding control.
Conclusions:
- Localized hemostasis strategies, including clot stabilization and fibrinolysis inhibition, offer promising avenues for managing nonsurgical bleeding.
- Further research into these mechanisms could reduce reliance on blood transfusions.
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.